Terminalia leiocarpa
Terminalia leiocarpa · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Terminalia leiocarpa is a botanical species that has garnered significant scientific interest due to its diverse pharmacological potential. Research into its crude methanol and ethyl acetate extracts has revealed a complex chemical profile containing compounds such as 1-Docosene, 1-OCTADECENE, and 2,3-(S)-hexahydroxydiphenoyl-D-glucose. These bioactive constituents contribute to the plant's documented anthelmintic activities, making it a subject of study for various parasitic threats. Specifically, investigations have focused on its efficacy against critical conditions including African Trypanosomiasis, Leishmania donovani, and Plasmodium falciparum. Consequently, the study of its various fractions continues to offer promising insights into the management of Malaria and other infectious diseases.
- Synonyms
- Anogeissus Schimperi · Anogeissus Leiocarpa · 7 more
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Terminalia leiocarpa is a versatile botanical species known by various regional and descriptive names. In certain contexts, it is referred to by the common names 光果欖仁 or 平滑果榆绿木. It is also frequently identified as 非洲樺樹 in various botanical records. Additionally, the plant is widely recognized by its traditional name, 马拉胶. Understanding these diverse naming conventions is essential for accurate identification and study.
Sources: Catalogue of Life (COL)
Synonyms
Terminalia leiocarpa is a botanical subject characterized by a complex web of taxonomic synonyms. It is widely recognized by the synonym Anogeissus leiocarpa, which serves as a primary alternative name for the species. Further classification includes specific forms such as Anogeissus leiocarpa f. grandifolia and Anogeissus leiocarpa f. parvifolia. The plant's identity is also linked to the variety Anogeissus leiocarpa var. schimperi. Finally, the nomenclature includes the direct synonym Anogeissus schimperi, reflecting the intricate history of its botanical naming.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Terminalia leiocarpa belongs to the vast kingdom Plantae, representing the diverse world of botanical life. Within this kingdom, the species is classified under the class Equisetopsida. It further resides in the order Myrtales, which helps scientists understand its evolutionary lineage. As a member of the family Combretaceae, it shares specific biological characteristics with its close relatives. Ultimately, this plant is defined by its placement within the genus Terminalia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Terminalia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Terminalia leiocarpa is a notable plant species with a widespread presence across the African continent. Its distribution is particularly prominent throughout Northeast Tropical Africa, spanning regions such as Chad, Eritrea, and Ethiopia. The species also establishes itself within the borders of Sudan and South Sudan, highlighting its ecological versatility. Beyond the northeast, its range extends into West Tropical Africa, specifically within the nation of Benin. This diverse geographic footprint illustrates the significant role the plant plays in various African ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Terminalia leiocarpa is a self-supporting plant characterized by its distinct tree growth form. This species typically reaches a maximum height of approximately 15 meters in many environments. However, under optimal conditions, it can grow even larger, reaching a peak height of up to 21.33625945 meters. Such structural versatility allows it to establish a significant presence within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Terminalia leiocarpa is a medicinal plant widely utilized in ethnoveterinary medicine to combat digestive parasitosis in small ruminants. Research has demonstrated that its methanol extracts possess significant anthelmintic activity, particularly in inhibiting the migration of Haemonchus contortus larvae. Through advanced fractionation and molecular networking, scientists have identified several key compounds within the plant, including ellagic acid, gallic acid, and various flavonoids. While individual components like ellagic and gallic acids show promise in inhibiting nematode viability, the overall efficacy of the plant may result from the synergistic effects of multiple compounds. These findings provide a vital scientific foundation for the potential development of new anthelmintic molecules derived from this species.
Compounds
Terminalia leiocarpa is a medicinal plant that possesses a complex chemical profile characterized by various bioactive phytochemicals. Scientific analysis has revealed that this species contains specific compounds such as 1-docosene and 1-octadecene. Additionally, the plant's chemical makeup includes the presence of 9-heptadecanone and cetene. Research into its molecular components also identifies the flavonoid astragalin as a constituent. These diverse chemical relationships highlight the plant's significant potential for pharmacological applications.
Conditions
Terminalia leiocarpa exhibits significant medicinal potential by treating digestive parasitosis, particularly through its active anthelmintic properties against gastrointestinal nematodes. The plant is also effective in combating African trypanosomiasis, which is a major socio-economic burden in sub-Saharan Africa. Research indicates that its bioactive compounds, such as ellagic acid and quercetin, play a role in treating Leishmania donovani. Furthermore, the plant demonstrates an ability to treat Plasmodium falciparum, a primary cause of malaria. Finally, Terminalia leiocarpa is recognized for its capacity to treat Trypanosoma brucei rhodesiense.
Preparations
Terminalia leiocarpa is prepared as a crude methanol extract to identify active components through bioassay-guided assays. It is also prepared as an ethyl acetate extract (EtOAc), which has demonstrated significant trypanocidal effects. Additionally, the plant is prepared as MeOH extracts that have proven highly effective in inhibiting larval migration. To further isolate active molecules, Terminalia leiocarpa is prepared as various fractions through column chromatography. These fractions are specifically analyzed to identify potent compounds like ellagic and gallic acids that contribute to its medicinal properties.